IP
53
3
CVS
27
2
BMY
40
-5
DFS
64
4
IPG
43
3
VFC
56
6
ADP
57
2
MSFT
55
2
DRI
74
5
LUV
45
3
NEE
39
9
ALL
37
3
APH
53
3
HAS
29
3
GD
42
4
AAP
26
5
HSY
32
3
ETN
64
4
AAPL
64
3
EIX
61
8
IP
53
3
CVS
27
2
BMY
40
-5
DFS
64
4
IPG
43
3
VFC
56
6
ADP
57
2
MSFT
55
2
DRI
74
5
LUV
45
3
NEE
39
9
ALL
37
3
APH
53
3
HAS
29
3
GD
42
4
AAP
26
5
HSY
32
3
ETN
64
4
AAPL
64
3
EIX
61
8
Financhill
Back

Treace Medical Concepts 10K Form

Sell
17

TMCI
Treace Medical Concepts

Last Price:
$6.96
Seasonality Move:
13.2%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TMCI News And Ratings

See the #1 stock for the next 7 days that we like better than TMCI

TMCI Financial Statistics

Sales & Book Value

Annual Sales: $187.1M
Cash Flow: $-14.7M
Price / Cash Flow: 0
Annual Sales: $1.68
Price / Book: 4.13

Profitability

EPS (TTM): -0.99220
Net Income (TTM): $-61.5M
Gross Margin: $151.9M
Return on Equity: -49.68%
Return on Assets: -26.2%

Treace Medical Concepts Earnings Forecast

Key Treace Medical Concepts Financial Ratios

  • The Gross Profit Margin over the past 5 years for TMCI is 81.20%.
  • The Selling, General & Administrative Expenses for TMCI have been equal to 100.43% of Gross Profit Margin.
  • The Research & Development expenses have been 8.25% of Revenue.
  • The Interest Expense is -10.43% of Operating Income.
  • The Net Earning history of TMCI is -26.47% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

Treace Medical Concepts Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: TMCI
Website: treace.com

Debt

Debt-to-Equity Ratio: 0.51
Current Ratio: 4.12
Quick Ratio: 2.8

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TMCI Technical Analysis vs Fundamental Analysis

Sell
17
Treace Medical Concepts (TMCI) is a Sell

Is Treace Medical Concepts a Buy or a Sell?